1. Home
  2. CETY vs TVRD Comparison

CETY vs TVRD Comparison

Compare CETY & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clean Energy Technologies Inc.

CETY

Clean Energy Technologies Inc.

SELL

Current Price

$0.90

Market Cap

11.6M

Sector

Utilities

ML Signal

SELL

Logo Tvardi Therapeutics Inc.

TVRD

Tvardi Therapeutics Inc.

SELL

Current Price

$0.99

Market Cap

12.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CETY
TVRD
Founded
1993
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.6M
12.6M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
CETY
TVRD
Price
$0.90
$0.99
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $8.75
AVG Volume (30 Days)
19.5K
★ 184.7K
Earning Date
12-01-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 79.01
EPS
★ N/A
N/A
Revenue
★ $957,633.00
$911,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 959.30
52 Week Low
$0.46
$0.77
52 Week High
$2.98
$5.69

Technical Indicators

Market Signals
Indicator
CETY
TVRD
Relative Strength Index (RSI) 44.80 43.90
Support Level $0.85 $0.85
Resistance Level $1.04 $1.09
Average True Range (ATR) 0.09 0.17
MACD 0.00 0.00
Stochastic Oscillator 45.45 20.86

Price Performance

Historical Comparison
CETY
TVRD

About CETY Clean Energy Technologies Inc.

Clean Energy Technologies Inc develop renewable energy products and solutions and establish partnerships in renewable energy that make environmental and economic sense. Its segments are Waste Heat Recovery Solutions - It recycle wasted heat produced in manufacturing, waste to energy and power generation. Waste to Energy Solutions - It convert waste products created in manufacturing, agriculture, wastewater treatment plants and other industries to electricity, renewable natural gas hydrogen and bio char. Engineering, Consulting and Project Management Solutions - It provide power generation, waste to energy, and heat recovery, Procurement and Construction (EPC) services to municipal and industrial customers. It generates majority of revenue from United States followed by International.

About TVRD Tvardi Therapeutics Inc.

Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need. Its pipeline includes two oral, small molecule STAT3 inhibitors: TTI-101 and TTI-109. TTI-101 is its first-generation direct STAT3 inhibitor, currently in Phase 1b/2 clinical development in hepatocellular carcinoma (HCC). TTI-109 is a phosphate prodrug of TTI-101 that is mechanistically identical to its parent molecule but is designed to enhance its ability to target STAT3.

Share on Social Networks: